JP2024125140A5 - - Google Patents
Info
- Publication number
- JP2024125140A5 JP2024125140A5 JP2023083815A JP2023083815A JP2024125140A5 JP 2024125140 A5 JP2024125140 A5 JP 2024125140A5 JP 2023083815 A JP2023083815 A JP 2023083815A JP 2023083815 A JP2023083815 A JP 2023083815A JP 2024125140 A5 JP2024125140 A5 JP 2024125140A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- tumor
- pharmaceutical composition
- chemotherapeutic agent
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310201602.2A CN116407640B (zh) | 2023-03-03 | 2023-03-03 | 包含阿兹夫定和化疗试剂的抗肿瘤药物组合物 |
| CN202310201602.2 | 2023-03-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024125140A JP2024125140A (ja) | 2024-09-13 |
| JP2024125140A5 true JP2024125140A5 (enExample) | 2026-04-20 |
Family
ID=86497784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023083815A Pending JP2024125140A (ja) | 2023-03-03 | 2023-05-22 | アズブジンと化学療法剤とを含む抗腫瘍医薬組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12268702B2 (enExample) |
| EP (1) | EP4424316B1 (enExample) |
| JP (1) | JP2024125140A (enExample) |
| KR (1) | KR20250167640A (enExample) |
| CN (1) | CN116407640B (enExample) |
| TW (1) | TW202435896A (enExample) |
| WO (1) | WO2024183645A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116407640B (zh) * | 2023-03-03 | 2025-10-31 | 河南真实生物科技有限公司 | 包含阿兹夫定和化疗试剂的抗肿瘤药物组合物 |
| CN116196325A (zh) * | 2023-03-10 | 2023-06-02 | 河南真实生物科技有限公司 | 包含阿兹夫定的免疫调节剂组合物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2252584C (en) * | 1996-04-26 | 2008-06-10 | Magainin Pharmaceuticals Inc. | Treatment of carcinomas using squalamine in combination with other anti-cancer agents |
| CN102000103B (zh) * | 2009-12-21 | 2011-12-21 | 郑州大学 | 2’-氟-4’-叠氮-核苷类似物或其盐的药物应用 |
| JP6290187B2 (ja) * | 2012-05-11 | 2018-03-07 | クランツ，アレクサンダー | 癌の処置のためのタンパク質の部位特異的標識及び標的送達 |
| JP6878417B2 (ja) * | 2016-02-17 | 2021-05-26 | トリアステック インコーポレイテッド | 剤形およびそれらの使用 |
| BR112019003946A2 (pt) * | 2016-08-31 | 2019-05-21 | Fujifilm Corporation | agente antitumoral, reforçador do efeito antitumoral e kit antitumoral |
| EP3820879B1 (en) * | 2018-06-29 | 2024-11-06 | Changchun Changcheng Pharmaceutical Technology Co., LTD | Phosphorus-containing prodrugs of gemcitabine |
| US20220110963A1 (en) * | 2019-01-02 | 2022-04-14 | The General Hospital Corporation | Reverse transcriptase blocking agents and methods of using the same |
| LT4106757T (lt) * | 2020-04-16 | 2023-11-10 | Mereo Biopharma 4 Limited | Neutrofilų elastazės inhibitoriaus alvelestato panaudojimas kvėpavimo sistemos ligų, nulemtų alfa-1 antitripsino nepakankamumo, gydymui |
| US20230218644A1 (en) * | 2020-04-16 | 2023-07-13 | Som Innovation Biotech, S.A. | Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus |
| WO2022066882A1 (en) * | 2020-09-23 | 2022-03-31 | Oncolinea Pharmaceuticals, Inc. | Method for treating cancer with a reverse transcriptase inhibitor |
| CN116407640B (zh) * | 2023-03-03 | 2025-10-31 | 河南真实生物科技有限公司 | 包含阿兹夫定和化疗试剂的抗肿瘤药物组合物 |
-
2023
- 2023-03-03 CN CN202310201602.2A patent/CN116407640B/zh active Active
- 2023-05-22 EP EP23174495.4A patent/EP4424316B1/en active Active
- 2023-05-22 US US18/200,000 patent/US12268702B2/en active Active
- 2023-05-22 JP JP2023083815A patent/JP2024125140A/ja active Pending
-
2024
- 2024-03-01 TW TW113107343A patent/TW202435896A/zh unknown
- 2024-03-01 KR KR1020257033468A patent/KR20250167640A/ko active Pending
- 2024-03-01 WO PCT/CN2024/079626 patent/WO2024183645A1/zh not_active Ceased